Darwin Fitness Launches Specialized Personal Training Program For Clients Using GLP-1 Weight Loss Medications
Jean-Sebastien Fabre (Darwin Fitness | Owner) with two of his actual clients Darwin Fitness GLP-1 fitness & nutrition coaching for ...
Lexaria Bioscience Corp.: Lexaria's DehydraTECH-tirzepatide Oral Capsules Achieve Comparable Levels in Bloodstream as Eli Lilly's Injectable Zepbound
More consistent accumulation demonstrated in bloodstream over a one-week duration with once-daily DehydraTECH-tirzepatide oral capsules as compared to once-weekly injection of Zepbound®As previously a ...
BioSpace4h
GLP-1 Drug Boom Recalls the Rise of PD-1 Checkpoint Inhibitors
The explosion of GLP-1 weight loss drugs is reminiscent of the early days of PD-1 inhibitors, but key market differences ...
Dr. Roach: A GLP-1 agonist can help reduce weight, sleep apnea and more
There are early and suggestive data that GLP-1 drugs reduce alcohol cravings. A large cohort of people with alcohol use ...
MarketBeat on MSN21h
Is Viking Therapeutics the Next Blockbuster GLP-1 Stock?
When it comes to clinical weight-loss treatments, GLP-1 therapies have taken the medical sector by storm. What started as off ...
What to Know About GLP-1 Medications with Dr. Nima Mowzoon
GLP-1 medications are changing the way we approach weight loss and chronic conditions. Dr. Nima Mowzoon of UBI Telehealth ...
Jim Cramer Sees General Mills (GIS) Struggling as GLP-1 Weight Loss Drugs Take Over
We recently published a list of 8 Stocks in Focus Under Jim Cramer’s Game Plan. In this article, we are going to take a look at where General Mills, Inc. (NYSE:GIS) stands against other stocks in ...
The Cardiology Advisor20h
GLP-1RA Discontinuation More Common in Obesity Without T2D
GLP-1RA discontinuation and lack of reinitiation was more common among patients with obesity and without type 2 diabetes than with type 2 diabetes.